6-[4-[4-(Benzyloxy)phenoxy]piperidin-1-yl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine → 4-[[1-[3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]oxy]phenol
반응식
C([O:8][C:9]1[CH:34]=[CH:33][C:12]([O:13][CH:14]2[CH2:19][CH2:18][N:17]([C:20]3[CH:21]=[CH:22][C:23]4[N:24]([C:26]([C:29]([F:32])([F:31])[F:30])=[N:27][N:28]=4)[N:25]=3)[CH2:16][CH2:15]2)=[CH:11][CH:10]=1)C1C=CC=CC=1>[Pd].CO>[F:32][C:29]([F:30])([F:31])[C:26]1[N:24]2[N:25]=[C:20]([N:17]3[CH2:16][CH2:15][CH:14]([O:13][C:12]4[CH:33]=[CH:34][C:9]([OH:8])=[CH:10][CH:11]=4)[CH2:19][CH2:18]3)[CH:21]=[CH:22][C:23]2=[N:28][N:27]=1참가 물질
4
실험 절차
10% Palladium on carbon (0.574 g, 0.54 mmol) was added to 6-[4-[4-(benzyloxy)phenoxy]piperidin-1-yl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine (2.53 g, 5.39 mmol) in MeOH (30 mL) under an atmosphere of hydrogen. The resulting suspension was stirred at ambient temperature for 24 hours. The reaction mixture was evaporated. The crude product was purified by flash silica chromatography, elution gradient 0 to 3% MeOH in DCM. Pure fractions were evaporated to dryness to afford 4-[[1-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]oxy]phenol (1.760 g, 86%) as a gum which crystallised on standing.
후처리
- customThe reaction mixture was evaporated
- customThe crude product was purified by flash silica chromatography, elution gradient 0 to 3% MeOH in DCM
- customPure fractions were evaporated to dryness
출처 및 근거
- ORD 기록
- ord-98db2e60edc243f4b8cbad6b6b0d09fb
- 출처 데이터셋
- uspto-grants-2011_08
- 특허 번호
- US08003649B2
반응 노트
불러오는 중…